6 news items
Paladin Labs Announces Approval of WAKIX® (pitolisant hydrochloride tablets) For Use in Pediatric Patients in Canada
ENDPQ
28 Mar 24
reliance on them, or any other forward-looking statements or information in this news release. Actual results may differ materially and adversely from
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
ENDPQ
26 Mar 24
to it and on assumptions it has made. Actual results may differ materially and adversely from current expectations based on a number of factors
Endo Announces Confirmation of Plan of Reorganization
ENDPQ
19 Mar 24
currently available to it and on assumptions it has made. Actual results may differ materially and adversely from current expectations based on a number
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
ENDPQ
12 Mar 24
of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign material
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
ENDPQ
6 Mar 24
materially from such expectations, as further discussed below under the heading "Cautionary Note Regarding Forward-Looking Statements
cgez8g cl8zkjqskcso114wv0b7rgvotwkpz5ejw8w
ENDPQ
29 Feb 24
currently available to it and on assumptions it has made. Actual results may differ materially and adversely from current expectations based
- Prev
- 1
- Next